Cargando…

The Clinical Application of Neoantigens in Esophageal Cancer

Esophageal cancer (EC) is a common malignant tumor with poor prognosis, and current treatments for patients with advanced EC remain unsatisfactory. Recently, immunotherapy has been recognized as a new and promising approach for various tumors. EC cells present a high tumor mutation burden and harbor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Yi-Min, Zhuo, Yue, Chen, Long-Qi, Yuan, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353328/ https://www.ncbi.nlm.nih.gov/pubmed/34386424 http://dx.doi.org/10.3389/fonc.2021.703517

Ejemplares similares

Personalized Neoantigen-Pulsed DC Vaccines: Advances in Clinical Applications
por: Tang, Lin, et al.
Publicado: (2021)

The Role of Neoantigens in Cancer Immunotherapy
por: Zhu, Yueting, et al.
Publicado: (2021)

Systematically Characterizing A-to-I RNA Editing Neoantigens in Cancer
por: Zhou, Chi, et al.
Publicado: (2020)

Mechanisms of Neoantigen-Targeted Induction of Pyroptosis and Ferroptosis: From Basic Research to Clinical Applications
por: Yu, Jie, et al.
Publicado: (2021)

Efficacy and Safety of Immune Checkpoint Inhibitor in Advanced Esophageal Squamous Cell Carcinoma: A Meta-Analysis
por: Gu, Yi-Min, et al.
Publicado: (2021)

Editorial: The Clinical Application of Neoantigens
por: Zhou, Jian-Guo, et al.
Publicado: (2022)

The Ways of Isolating Neoantigen-Specific T Cells
por: Li, Qing, et al.
Publicado: (2020)

Cancer Neoantigens: Challenges and Future Directions for Prediction, Prioritization, and Validation
por: Borden, Elizabeth S., et al.
Publicado: (2022)

Artificial intelligence applied in neoantigen identification facilitates personalized cancer immunotherapy
por: Cai, Yu, et al.
Publicado: (2023)

Personal Neoantigens From Patients With NSCLC Induce Efficient Antitumor Responses
por: Zhang, Wei, et al.
Publicado: (2021)

Development and Validation of a Clinical Prognostic Nomogram for Esophageal Adenocarcinoma Patients
por: Shao, Chen-ye, et al.
Publicado: (2021)

Neoantigens and their clinical applications in human gastrointestinal cancers
por: Eshkiki, Zahra Shokati, et al.
Publicado: (2022)

Effect of circumferential resection margin status on survival and recurrence in esophageal squamous cell carcinoma with neoadjuvant chemoradiotherapy
por: Gu, Yi-Min, et al.
Publicado: (2022)

A phase I dose-escalation study of neoantigen-activated haploidentical T cell therapy for the treatment of relapsed or refractory peripheral T-cell lymphoma
por: Chen, Yuan, et al.
Publicado: (2022)

Recent Development and Clinical Application of Cancer Vaccine: Targeting Neoantigens
por: Pan, Ren-You, et al.
Publicado: (2018)

Gut Microbiota for Esophageal Cancer: Role in Carcinogenesis and Clinical Implications
por: Zhou, Jianfeng, et al.
Publicado: (2021)

A Comprehensive Survey of Genomic Mutations in Breast Cancer Reveals Recurrent Neoantigens as Potential Therapeutic Targets
por: Zhou, Si, et al.
Publicado: (2022)

Neoantigen landscape in metastatic nasopharyngeal carcinoma
por: Lin, Mei, et al.
Publicado: (2021)

Clinical Application of Oral Meglumine Diatrizoate Esophagogram in Screening for Esophageal Fistula During Radiotherapy or Chemoradiotherapy for Esophageal Cancer
por: Wu, Rong, et al.
Publicado: (2020)

Tumor neoantigens: Novel strategies for application of cancer immunotherapy
por: GUAN, HANYANG, et al.
Publicado: (2023)

The application of radiomics in esophageal cancer: Predicting the response after neoadjuvant therapy
por: Guo, Hai, et al.
Publicado: (2023)

Neoantigens in precision cancer immunotherapy: from identification to clinical applications
por: Zhang, Qiao, et al.
Publicado: (2022)

Genetically Modified T Cells for Esophageal Cancer Therapy: A Promising Clinical Application
por: Zhu, Yu-Ge, et al.
Publicado: (2021)

Beyond Tumor Mutation Burden: Tumor Neoantigen Burden as a Biomarker for Immunotherapy and Other Types of Therapy
por: Wang, Peipei, et al.
Publicado: (2021)

Therapy of genomic unstable solid tumours (WHO grade 3/4）in clinical stage III/IV using individualised neoantigen tumour peptides-INP trial (individualised neoantigen tumour peptides immunotherapy): study protocol for an open-label, non-randomised, prospective, single-arm trial
por: Wang, Ling, et al.
Publicado: (2022)

Identifying Potential Neoantigens for Cervical Cancer Immunotherapy Using Comprehensive Genomic Variation Profiling of Cervical Intraepithelial Neoplasia and Cervical Cancer
por: Bao, Chaohui, et al.
Publicado: (2021)

Targeting neoantigens for cancer immunotherapy
por: Zhao, Xuan, et al.
Publicado: (2021)

Tumor neoantigens: from basic research to clinical applications
por: Jiang, Tao, et al.
Publicado: (2019)

Characterization of genomic alterations and neoantigens and analysis of immune infiltration identified therapeutic and prognostic biomarkers in adenocarcinoma at the gastroesophageal junction
por: Lao, Yueqiong, et al.
Publicado: (2022)

Cancer of Pharyngoesophageal Junction: A Different Subtype From Hypopharyngeal and Cervical Esophageal Cancer?
por: Li, Xiaoyu, et al.
Publicado: (2021)

No survival benefit could be obtained from adjuvant radiotherapy in esophageal cancer treated with neoadjuvant chemotherapy followed by surgery: A SEER-based analysis
por: Zheng, Si-Yue, et al.
Publicado: (2022)

Neoantigens and their potential applications in tumor immunotherapy
por: Fang, Xianzhu, et al.
Publicado: (2022)

Integrating Clinical Data and Attentional CT Imaging Features for Esophageal Fistula Prediction in Esophageal Cancer
por: Xu, Yiyue, et al.
Publicado: (2021)

Dosimetric Evaluation and Clinical Application of Radioactive Iodine-125 Brachytherapy Stent in the Treatment of Malignant Esophageal Obstruction
por: Ji, Zhe, et al.
Publicado: (2022)

The Least Nodal Disease Burden Defines the Minimum Number of Nodes Retrieved for Esophageal Squamous Cell Carcinoma
por: Zhang, Hanlu, et al.
Publicado: (2022)

Progress in Neoantigen Targeted Cancer Immunotherapies
por: Han, Xue-Jiao, et al.
Publicado: (2020)

Editorial: Chemotherapy in esophageal cancer
por: Chen, Jiang, et al.
Publicado: (2022)

NeoFox: annotating neoantigen candidates with neoantigen features
por: Lang, Franziska, et al.
Publicado: (2021)

A nomogram model to individually predict prognosis for esophageal cancer with synchronous pulmonary metastasis
por: Zhang, Xin-yao, et al.
Publicado: (2023)

Overcoming resistance to PD-1/PD-L1 inhibitors in esophageal cancer
por: Cheng, Chao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j84hij4l9gqpouiok4okh0rtf9